Skip to content

13F-HR filed by HarbourVest Partners LLC

HarbourVest Partners LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-13, with 30 holding rows worth $190,196,000.

Accession
0000950123-15-002067
Filed
2015-02-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 30 entries on the cover page, a total value of $190,196,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $190,197,000 with VALUE read as thousands by filing date, 13F file number 028-14156. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WAYFAIR INC94419L101CL A4,413,282$87,604,000thousands by filing date
SERVICEMASTER GLOBAL HOLDING81761R109COMMON STOCK1,666,666$44,617,000thousands by filing date
FINJAN HLDGS INC31788H303COM NEW4,303,435$11,619,000thousands by filing date
TABLEAU SOFTWARE INC87336U105CL A80,998$6,865,000thousands by filing date
ENVIVIO INC29413T106COM3,639,939$4,878,000thousands by filing date
VIPSHOP HLDGS LTD SPONSORED ADS A92763W103ADR246,304$4,813,000thousands by filing date
GAIN CAPITAL HOLDINGS INC36268W100COM523,508$4,722,000thousands by filing date
GOGO INC38046C109COM186,178$3,078,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM51,037$2,858,000thousands by filing date
SOLARCITY CORP83416T100COM38,870$2,079,000thousands by filing date
MARKETO INC57063L107COM62,798$2,055,000thousands by filing date
ZULILY INC989774104CL A85,355$1,997,000thousands by filing date
ACCELERON PHARMA INC00434H108COM51,163$1,993,000thousands by filing date
Foundation Medicine Inc350465100COM87,991$1,955,000thousands by filing date
HOMEAWAY INC43739Q100COM50,244$1,496,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM39,318$1,364,000thousands by filing date
MACROGENICS INC556099109COM38,452$1,349,000thousands by filing date
ARDELYX INC039697107COM47,520$898,000thousands by filing date
CARA THERAPEUTICS INC140755109COM67,452$672,000thousands by filing date
CHANNELADVISOR CORP159179100COM28,512$615,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM28,443$598,000thousands by filing date
RetailMeNot Inc76132B106COM SER 140,420$591,000thousands by filing date
HYPERION THERAPEUTICS INC44915N101COM18,758$450,000thousands by filing date
E2OPEN INC29788A104COM35,140$338,000thousands by filing date
KALOBIOS PHARMACEUTICALS INC48344T100COM107,604$186,000thousands by filing date
OPOWER INC68375Y109COM7,939$113,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM6,974$108,000thousands by filing date
VERACYTE INC COM92337F107Stock11,101$107,000thousands by filing date
EPIZYME INC29428V104COM5,196$98,000thousands by filing date
ARISTA NETWORKS INC040413106COM1,341$81,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-15-002067this filing2015-02-13acceptance time not in the bulk data set